Project Grant F32AI178920
Award Date
11/5/24
Completion Date
6/30/26
Dollars Obligated
$149K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $477,226 to the University of Washington to investigate antiviral systems in microbial eukaryotes, with a focus on how Acanthamoeba spp. defend against giant viruses in the Megavirales family. The project aims to uncover viral proteins that antagonize known viral restriction pathways in Acanthamoeba, as well as identify new antiviral systems...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the role of cells, antigens, and antibodies in controlling virus infections through antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytolysis (CDC). The $318,085 award, running from December 2024 to November 2029, aims...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the mechanisms used by adenovirus to manipulate host RNA-binding proteins and overcome host defenses.
The $729,006 grant awarded on January 14, 2025 will enable researchers at The Children's Hospital of Philadelphia to employ innovative proteomic and imaging technologies to investigate how...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to investigate the molecular mechanisms underlying the innate immune response to West Nile virus (WNV) infection. The $595,992 award to the University of Washington will support research efforts to identify the specific viral RNA species and molecular motifs that activate the RIG-I-like receptor signaling pathway, a key component of the...
This $161,616 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research by the University of Vermont to better understand the development of mucosal immunity to poliovirus. The research aims to characterize human immune responses during oral poliovirus vaccine infection, investigate the impact of vaccine priming and gut microbiota on mucosal immunity, and evaluate the potential of a novel...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $658,273 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Massachusetts Medical School to study how the Herpes Simplex Virus 1 (HSV-1) activates and inhibits the NLRP1 inflammasome pathway, and to understand the role of NLRP1 in antiviral defense in human skin. The key objectives are to: 1) determine how the HSV-1 ICP0 protein activates stress-activated protein kinases and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $981,781 to the University of Washington to investigate the mechanisms by which intestinal helminth infections promote enteric viral infections, specifically adenoviral gastroenteritis.
The research aims to determine if helminths can impair the adaptive immune response against the adenovirus, disrupt early interferon responses, or utilize...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $197,366 to The Washington University to conduct research on understanding the mechanisms that allow the human immune system to naturally restrict a specific subset of the HIV virus. The 5-year study aims to:
Characterize the molecular mechanisms driving the restriction of X4-tropic HIV replication in the presence of R5-tropic...
This Project Grant award under the Allergy and Infectious Diseases Research program (CFDA 93.855) of the National Institute of Allergy and Infectious Diseases (NIAID) supports research to define the role of novel host proteins in the alphavirus life cycle. The $730,800 award, effective June 1, 2024 through April 30, 2026, will fund studies to characterize the pro-viral functions of four specific host proteins in alphavirus infection. The research aims to provide fundamental information on...
This federal Project Grant award in the amount of $1,179,316.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award is focused on understanding the mechanisms that regulate CD8 T cell responses during chronic viral infection, with the goal of improving immunotherapies to increase T cell function and reduce viral load. Key aspects of the research include:
Determining the role of...